REducing STEroids in Relapsing Nephrotic syndrome: the RESTERN study— protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention study

INTRODUCTION: Oral corticosteroids are the first-line treatment for idiopathic childhood nephrotic syndrome. Most children experience several relapses, needing repeated courses of corticosteroid therapy. This exposes them to side effects and long-term complications. For most patients, long-term prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Schijvens, A M, Dorresteijn, E M, Roeleveld, N, ter Heine, R, van Wijk, J A E, Bouts, A H M, Keijzer-Veen, M G, van de Kar, N C A J, van den Heuvel, L P W J, Schreuder, M F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Paediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623563/
https://www.ncbi.nlm.nih.gov/pubmed/28963315
http://dx.doi.org/10.1136/bmjopen-2017-018148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623563/
https://www.ncbi.nlm.nih.gov/pubmed/28963315
http://dx.doi.org/10.1136/bmjopen-2017-018148

Ejemplares similares